Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-25943

Xla Wt + tgfbi MO, Baxi AB et al. (2023)

Experiment + Assay: Xla Wt + tgfbi MO + NF32 (in situ hybridization)
Background: Xla.pigmentedNasco
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection tgfbi MO1 tgfbi (Xla)
 NF stage 16
morpholino injection tgfbi MO2 tgfbi (Xla)
 NF stage 16
Conditions:
Assay Type Assay Stages Antibody
in situ hybridization NF stage 32  
Anatomical Phenotypes: decreased size of the otic vesicle
Expression Phenotypes (3):
decreased amount dlx5.L expression in otic vesicle
decreased amount dlx5.L expression in pharyngeal arch
decreased amount pax2.L expression in otic vesicle
Source: Fig. 7 C r1c2, r2c2; D E
Article: XB-ART-60285, PubMed